![]() | Up a level |
Alexander, T., Sarfert, R., Klotsche, J., Rubbert-Roth, A., Lorenz, H. -M., Rech, J., Hoyer, B., Cheng, Q., Waka, A., Taddeo, A., Kuehl, A. A., Schett, G., Burmester, G. -R., Radbruch, A., Hiepe, F. and Voll, R. E. (2014). THE PROTEASOME INHIBITOR BORTEZOMIB AMELIORATES REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A PROSPECTIVE MULTI-CENTRE OBSERVATIONAL STUDY. Ann. Rheum. Dis., 73. S. 530 - 531. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Juche, A., Siegert, E., Mueller-Ladner, U., Riemekasten, G., Guenther, C., Koetter, I, Henes, J., Blank, N., Voll, R. E., Ehrchen, J., Schmalzing, M., Susok, L., Schmeiser, T., Sunderkoetter, C., Distler, J., Worm, M., Kreuter, A., Horvath, N., Schoen, M. P., Korsten, P., Zeidler, G., Pfeiffer, C., Krieg, T., Hunzelmann, N. and Moinzadeh, P. . Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany. Z. Rheumatol.. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250